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Background
Sensor proteins that detect cGMP are valuable tools to
analyse the molecular mechanisms underlying cGMP’s
manifold physiological functions. These cGMP sensors
allow for visualization and quantification of cGMP in
living cells, in real time, and at high spatial and tem-
poral resolution. For instance, they allow one to study
sub-cellular cGMP compartments, and combined with
multi-photon microscopy, they can provide new insights
into complex biological processes, which can be ana-
lysed only in live animals.
Results
To monitor cGMP signals in vivo, we have generated
and characterized transgenic mouse lines expressing the
fluorescence resonance energy transfer (FRET)-based
cGi500 sensor (cGMP indicator with an EC50 value for
cGMP of 500 nM, [1]). One mouse line produced by
random transgenesis expresses cGi500 in vascular and
visceral smooth muscle. Other mouse lines were created
by targeted modification of the ROSA26 locus; these
lines either show ubiquitous cGi500 expression, or they
can be used for Cre/lox-dependent, tissue-specific
cGi500 expression. These cGi500-transgenic mice are
healthy and fertile, and do not show obvious adverse
phenotypes.
Primary cells isolated from cGi500-expressing mice,
including platelets, neural cells, and smooth muscle cells
were used for FRET imaging experiments. NO-induced
cGMP synthesis via soluble guanylyl cyclase was observed
in the majority of cell types, while cGMP responses to
atrial or C-type natriuretic peptides differed between cell
types. Moreover, NO-induced cGMP elevations could be
observed in the vasculature of retinas isolated from
cGi500-expressing animals. Importantly, the feasibility of
FRET-based cGMP imaging in living animals was demon-
strated by intravital microscopy of anesthetized cGi500-
transgenic mice. By epifluorescence FRET microscopy we
could visualize transient NO-induced cGMP signals in
arterial walls of the cremaster muscle. Furthermore, we
used multi-photon microscopy in a dorsal skinfold cham-
ber model and were able to record NO-elicited FRET
changes in subcutaneous vessels.
Conclusion
All in all, these cGMP sensor mouse lines represent
valuable resources for studies with cGi500-expressing
primary cells, and, importantly, they can also be used
for intravital imaging studies with live animals. We
believe that these mouse lines will find widespread
applications and that in combination with other genetic
mouse models they can contribute to improve our
understanding of cGMP-modulated physiological or dis-
ease-associated processes.
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